These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20060154)

  • 1. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Mod Pathol; 2002 Sep; 15(9):904-13. PubMed ID: 12218207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Oct; 35(10):1484-97. PubMed ID: 21881484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
    Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
    Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
    Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
    Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.
    Hasebe T; Tamura N; Iwasaki M; Okada N; Akashi-Tanaka S; Hojo T; Shimizu C; Adachi M; Fujiwara Y; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Mod Pathol; 2010 Apr; 23(4):581-92. PubMed ID: 20118911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
    Yue M; Li F; Deng HY; Zhang LL; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
    Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
    Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried Diff-Quik smears.
    Khan MZ; Haleem A; Al Hassani H; Kfoury H
    Diagn Cytopathol; 2003 Oct; 29(4):185-93. PubMed ID: 14506669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy.
    Nixon AJ; Schnitt SJ; Gelman R; Gage I; Bornstein B; Hetelekidis S; Recht A; Silver B; Harris JR; Connolly JL
    Cancer; 1996 Oct; 78(7):1426-31. PubMed ID: 8839547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Node-related factors and survival in node-positive breast carcinomas.
    Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
    Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.
    Manders P; Tjan-Heijnen VC; Span PN; Grebenchtchikov N; Geurts-Moespot A; van Tienoven DT; Beex LV; Sweep FC
    Cancer; 2004 Aug; 101(3):486-94. PubMed ID: 15274061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.